FrancophonIA/ELRC3.0 huggingface dataset:
English: Therapy should be initiated by a healthcare provider experienced in the management of HIV infection.
Icelandic: Læknir með reynslu af meðhöndlun HIV sýkingar skal hefja meðferðina.
English: Based on theoretical considerations REZOLSTA is expected to increase these PDE-5 inhibitor plasma concentrations.
Icelandic: Byggt á fræðilegum athugunum er búist við að REZOLSTA auki plasmaþéttni þessara PDE-5 hemla.
English: Based on theoretical considerations REZOLSTA is expected to increase maraviroc plasma concentrations.
Icelandic: Byggt á fræðilegum athugunum er búist við að REZOLSTA auki plasmaþéttni maravirocs.
English: Based on theoretical considerations REZOLSTA is expected to increase salmeterol plasma concentrations.
Icelandic: Byggt á fræðilegum athugunum er búist við að REZOLSTA auki plasmaþéttni salmeterols.
English: Darunavir and cobicistat are metabolised by the hepatic system.
Icelandic: Darunavir og cobicistat umbrotna í lifur.
English: - Bosentan (to treat high blood pressure in the pulmonary circulation) - Buspirone, clorazepate, diazepam, estazolam, flurazepam, zolpidem, midazolam when used as injection (medicines to treat trouble with sleeping and/or anxiety) - Metformin (to treat type 2 diabetes) - Fentanyl, oxycodone, tramadol (to treat pain).
Icelandic: - Buspiron, clorazepat, diazepam, estazolam, flurazepam, zolpidem, midazolam þegar gefið sem inndæling (lyf við svefnvandamálum og/eða kvíða).
English: Type AE
Icelandic: Tegund AE Tegund C
English: Cobicistat Following oral administration of
Icelandic: Cobicistat Eftir inntöku
English: Gastrointestinal disorders Very common diarrhoea, nausea
Icelandic: Meltingarfæri Mjög algengar niðurgangur, ógleði
English: Caution should be exercised when combining one of these anti-neoplastic agents with REZOLSTA.
Icelandic: Gæta skal varúðar þegar eitt þessara æxlishemjandi lyfja er gefið samhliða REZOLSTA.
English: Medicinal products that affect darunavir/cobicistat exposure
Icelandic: Lyf sem hafa áhrif á útsetningu fyrir darunaviri/cobicistati
English: The combination of rifampicin and REZOLSTA is contraindicated (see section 4.3).
Icelandic: Ekki má nota rifampicin samhliða REZOLSTA (sjá kafla 4.3).
English: What REZOLSTA contains - The active substances are darunavir and cobicistat.
Icelandic: - Virku innihaldsefnin eru darunavir og cobicistat.
English: Therefore, therapy with REZOLSTA should not be initiated during pregnancy, and women who become pregnant during therapy with REZOLSTA should be switched to an alternative regimen (see sections 4.4 and 4.6).
Icelandic: Því skal ekki hefja meðferð með REZOLSTA á meðgöngu og skipta skal yfir á aðra meðferð hjá konum sem verða þungaðar meðan á meðferð með REZOLSTA stendur (sjá kafla 4.4 og 4.6).
English: Patients co-infected with hepatitis B and/or hepatitis C virus Limited information is available on the use of REZOLSTA in patients co-infected with hepatitis B and/or C virus.
Icelandic: C veiru Takmarkaðar upplýsingar liggja fyrir um notkun REZOLSTA hjá sjúklingum sem einnig eru sýktir af lifrarbólgu B og/eða lifrarbólgu C veiru.
English: Liver problems that may occasionally be severe have been reported.
Icelandic: Látið lækninn vita ef einhver eftirtalinna aukaverkana kemur fram Greint hefur verið frá lifrarvandamálum sem geta stundum verið alvarleg.
English: Increased CPK, myalgia, myositis and, rarely, rhabdomyolysis have been reported with the use of HIV protease inhibitors, particularly in combination with NRTIs.
Icelandic: CPK, vöðvaverkjum, vöðvaþrota og mjög sjaldan rákvöðvalýsu við notkun HIV próteasahemla, einkum í samsetningum með núkleósíð bakritahemlum.
English: Based on theoretical considerations REZOLSTA may alter warfarin plasma concentrations.
Icelandic: Byggt á fræðilegum athugunum má búast við að REZOLSTA breyti plasmaþéttni warfarins.
English: Rash
Icelandic: RAMs
English: Outcomes darunvir/ritonavir 800/100 mg once daily + OBR N = 294
Icelandic: Niðurstöður darunavir/ritonavir 800/100 mg einu sinni á sólarhring + OBR N
English: REZOLSTA does not require any special storage conditions.
Icelandic: Engin sérstök fyrirmæli eru um geymsluaðstæður REZOLSTA.
English: (most often the lips or the eyes) - severe rash with blisters and peeling skin, particularly around the mouth, nose, eyes and genitals.
Icelandic: Læknirinn mun útskýra þetta fyrir þér - ofnæmisviðbrögð eins og ofsakláði, veruleg bólga í húð og öðrum vefjum (oftast í vörum eða augum) - alvarleg útbrot með blöðrum og flögnun húðar, sérstaklega í kringum munn, nef, augu og kynfæri.
English: Concomitant administration of REZOLSTA with dabigatran or ticagrelor is contraindicated.
Icelandic: Ekki má nota REZOLSTA samhliða dabigatrani eða ticagrelori.
English: No dosage adjustment of REZOLSTA is necessary for patients with mild to moderate hepatic impairment.
Icelandic: Ekki þarf að aðlaga skammta REZOLSTA hjá sjúklingum með væga til í meðallagi skerta lifrarstarfsemi.
English: Co-administration of REZOLSTA and these anticonvulsants is contraindicated (see section 4.3).
Icelandic: Ekki má nota REZOLSTA samhliða þessum flogaveikilyfjum (sjá kafla 4.3).
English: Based on theoretical considerations REZOLSTA is expected to increase tenofovir plasma concentrations.
Icelandic: Byggt á fræðilegum athugunum er búist við að REZOLSTA auki plasmaþéttni tenofovirs.
English: Treatment-experienced darunavir/ritonavir 600/100 mg twice daily N = 296
Icelandic: darunavir/ritonavir 600/100 mg tvisvar á sólarhring
English: These patients received darunavir 800 mg once daily in combination with cobicistat 150 mg once daily with an investigator selected optimised background regimen (OBR) consisting of 2 active NRTIs.
Icelandic: 800 mg af darunaviri einu sinni á sólarhring ásamt 150 mg af cobicistati einu sinni á sólarhring og bakgrunnsmeðferð tveggja virkra núkleósíðbakritahemla sem valin var af rannsóknarlækni.
English: In these pharmacokinetic trials, the exposure of darunavir 800 mg boosted with cobicistat 150 mg was consistent with that observed when boosted with ritonavir 100 mg. Darunavir as a component of REZOLSTA is bioequivalent to darunavir 800 mg once daily in combination with cobicistat 150 mg once daily co-administered as single medicinal products (see section 5.2).
Icelandic: Darunavir sem hluti af REZOLSTA er jafngilt darunavir 800 mg einu sinni á sólarhring ásamt cobicistati 150 mg einu sinni á sólarhring þegar þau eru gefin sem tvö aðskilin lyf (sjá kafla 5.2).
English: Co-administration of REZOLSTA with alfuzosin is contraindicated (see section 4.3).
Icelandic: Ekki má nota REZOLSTA og alfuzosin samhliða (sjá kafla 4.3).
English: Therapy with REZOLSTA should not be initiated during pregnancy, and women who become pregnant during therapy with REZOLSTA should be switched to an alternative regimen (see sections 4.2 and 4.4).
Icelandic: Ekki skal hefja meðferð með REZOLSTA á meðgöngu og skipta skal yfir á aðra meðferð hjá konum sem verða þungaðar meðan á meðferð með REZOLSTA stendur (sjá kafla 4.2 og 4.4).
English: Therefore, therapy with REZOLSTA should not be initiated during pregnancy, and women who become pregnant during therapy with REZOLSTA should be switched to an alternative regimen (see sections 4.2 and 4.6).
Icelandic: Því skal ekki hefja meðferð með REZOLSTA á meðgöngu og skipta skal yfir á aðra meðferð hjá konum sem verða þungaðar meðan á meðferð með REZOLSTA stendur (sjá kafla 4.2 og 4.6).
English: Concomitant use of PDE-5 inhibitors for the treatment of erectile dysfunction with REZOLSTA should be done with caution.
Icelandic: Gæta skal varúðar við samhliða notkun PDE-5 hemla til meðhöndlunar á ristruflunum samhliða REZOLSTA.
English: REZOLSTA should not be used in paediatric patients below 3 years of age because of safety concerns (see sections 4.4 and 5.3).
Icelandic: REZOLSTA handa börnum yngri en 3 ára vegna öryggis (sjá kafla 4.4 og 5.3).
English: The combination of avanafil and REZOLSTA is contraindicated (see section 4.3).
Icelandic: Ekki má nota avanafil samhliða REZOLSTA (sjá kafla 4.3).
English: - Tell your doctor if you have had problems with your kidneys.
Icelandic: - Segðu lækninum frá því ef þú hefur áður fengið einkenni frá nýrum.
English: The most frequent serious reactions are acute renal failure, myocardial infarction, immune reconstitution inflammatory syndrome, thrombocytopenia, osteonecrosis, diarrhoea, hepatitis, and pyrexia.
Icelandic: Algengustu alvarlegu aukaverkanirnar eru bráð nýrnabilun, hjartadrep, heilkenni endurvirkjunar ónæmis, blóðflagnafæð, beindrep, niðurgangur, lifrarbólga og hækkaður líkamshiti.
English: Co-administration of tadalafil for the treatment of pulmonary arterial hypertension with REZOLSTA is not recommended.
Icelandic: Ekki er ráðlagt að nota tadalafil til meðhöndlunar á lungnaslagæðaháþrýstingi, samhliða REZOLSTA.
English: HIV-1 RNA < 50 copies/mL With Baseline
Icelandic: RNA < 50 eintök/ml meðalgildi HIV-1
English: In GS-US-216-130 baseline phenotype was not available
Icelandic: GS-US-216-130 er einarma, opin, III.
English: For further details, consult the maraviroc Summary of Product Characteristics.
Icelandic: Frekari upplýsingar má finna í samantekt á eiginleikum maravirocs.
English: Rifampicin to treat some infections such as tuberculosis Lurasidone, pimozide, quetiapine or sertindole to treat psychiatric conditions Ergot alkaloids like ergotamine, dihydroergotamine, ergometrine and methylergonovine to treat migraine headaches
Icelandic: Ergotalkalóíðar eins og ergotamin, dihydroergotamin, ergometrin og metýlergonovin við mígrenishöfuðverk
English: Therefore, co-administration of REZOLSTA and sildenafil when used for the treatment of pulmonary arterial hypertension is contraindicated (see section 4.3).
Icelandic: Þess vegna má ekki nota sildenafil, til meðhöndlunar á lungnaslagæðaháþrýstingi, samhliða REZOLSTA (sjá kafla 4.3).
English: There are no adequate and well controlled trials with darunavir, or cobicistat, in pregnant women.
Icelandic: Ekki hafa verið gerðar neinar fullnægjandi samanburðarrannsóknir á notkun darunavirs eða cobicistats hjá þunguðum konum.
English: Based on theoretical considerations REZOLSTA is expected to increase colchicine plasma concentrations.
Icelandic: Byggt á fræðilegum athugunum er búist við að REZOLSTA auki plasmaþéttni colchicins.
English: Refer to the Summary of Product Characteristics for PREZISTA for further information.
Icelandic: Frekari upplýsingar má finna í samantekt á eiginleikum PREZISTA.
English: (drug) hypersensitivity
Icelandic: (lyfja) ofnæmi
English: Based on theoretical considerations REZOLSTA is expected to increase these antifungal plasma concentrations, and darunavir and/or cobicistat plasma concentrations may be increased by the antifungals.
Icelandic: Byggt á fræðilegum athugunum er búist við að REZOLSTA auki plasmaþéttni þessara sveppalyfja og sveppalyfin gætu aukið plasmaþéttni darunavirs og/eða cobicistats.
English: Treatment-experienced darunavir/cobicistat 800/150 mg once daily + OBR N = 18
Icelandic: Sjúklingar sem hafa fengið meðferð áður darunavir/cobicistat 800/150 mg einu sinni á sólarhring + OBR N = 18
English: Based on theoretical considerations REZOLSTA is expected to increase alfentanil plasma concentrations.
Icelandic: Byggt á fræðilegum athugunum er búist við að REZOLSTA auki plasmaþéttni alfentanils.
English: The effects of REZOLSTA might be reduced if you take any of the following products.
Icelandic: Dregið getur úr áhrifum REZOLSTA ef eitthvað af eftirtöldu er notað samhliða.
English: - Oestrogen-based hormonal contraceptives and hormone replacement therapy.
Icelandic: - Getnaðarvarnarlyf með hormónum sem innihalda estrógen og uppbótarmeðferð með hormónum.
English: d (-25; 16)
Icelandic: N = 18
English: Common vomiting, abdominal pain, abdominal distension, dyspepsia, flatulence
Icelandic: Algengar uppköst, kviðverkir, uppþemba, meltingartruflun, vindgangur
English: Systemic dexamethasone should be used with caution when combined with REZOLSTA.
Icelandic: Gæta skal varúðar við notkun dexametasons til altækrar verkunar samhliða REZOLSTA.
English: Driving and using machines Do not operate machines or drive if you feel dizzy after taking REZOLSTA.
Icelandic: Þeir sem finna fyrir sundli eftir notkun REZOLSTA mega hvorki nota vélar né stunda akstur.
English: In the REZOLSTA arm of Phase III trial TMC114FD2HTX3001, mean eGFRCG change from baseline was -11.1 mL/min at week 48 and mean eGFRcystatin C change from baseline was +2.9 mL/min/1.73 m² at week 48.
Icelandic: stigs rannsókinni TMC114FD2HTX3001 var meðalbreyting eGFRCG frá upphafsgildi -11,1 ml/mín.
English: Based on theoretical considerations these antimycobacterials are expected to decrease darunavir and/or cobicistat plasma concentrations.
Icelandic: Byggt á fræðilegum athugunum má búast við að þessi lyf gegn mycobakteríum minnki plasmaþéttni darunavirs og/eða cobicistats.
English: Skin and subcutaneous tissue disorders Very common rash (including macular, maculopapular, papular, erythematous, pruritic rash, generalised rash, and allergic dermatitis)
Icelandic: Húð og undirhúð Mjög algengar útbrot (þ.m.t. blettótt, dröfnuörðu-, örðu- og roðaþotsútbrot, kláðaútbrot, almenn útbrot og ofnæmishúðbólga)
English: Pharmacotherapeutic group: Antivirals for systemic use, antivirals for treatment of HIV infection, combinations ATC code: J05AR14
Icelandic: Veirulyf til altækrar notkunar, veirulyf til meðferðar á HIV sýkingum, blöndur, ATC-flokkur:
English: If REZOLSTA is missed within 12 hours of the time it is usually taken, patients should be instructed to take the prescribed dose of REZOLSTA with food as soon as possible.
Icelandic: REZOLSTA skal gefa sjúklingum fyrirmæli um að taka ávísaðan REZOLSTA skammt með fæðu eins fljótt og hægt er.
English: urticaria
Icelandic: Aukaverkun
English: With baseline CD4+ cell count < 200
Icelandic: Upphafsgildi CD4+ frumutalningar < 200 Upphafsgildi CD4+ frumutalningar ≥ 200
English: REZOLSTA 800 mg/150 mg - film-coated tablets darunavir/cobicistat
Icelandic: REZOLSTA 800 mg/150 mg - filmuhúðaðar töflur darunavir/cobicistat
English: Hepatic impairment
Icelandic: Þreyta, þróttleysi
English: (CYP3A inhibition and/or P-gp inhibition)
Icelandic: (CYP3A hömlun og/eða P-gp hömlun)
English: Based on theoretical considerations REZOLSTA is expected to increase alfuzosin plasma concentrations.
Icelandic: Byggt á fræðilegum athugunum er búist við að REZOLSTA auki plasmaþéttni alfuzosins.
English: PHOSPHODIESTERASE, TYPE 5 (PDE-5) INHIBITORS For the treatment of erectile dysfunction Sildenafil Tadalafil Vardenafil
Icelandic: FOSFODIESTERASA, GERÐ 5 (PDE-5)
English: - Rifabutin (against bacterial infections) - Tadalafil, sildenafil, vardenafil (for erectile dysfunction or high blood pressure in the pulmonary circulation) - Amitriptyline, desipramine, imipramine, nortriptyline, paroxetine, sertraline, trazodone (to treat depression and anxiety) - Maraviroc (to treat HIV infection) - Colchicine (to treat gout or familial Mediterranean fever).
Icelandic: - Amitriptylin, desipramin, imipramin, nortriptylin, paroxetin, sertralin, trazodon (við þunglyndi og kvíða).
English: Efficacy of darunavir/cobicistat fixed-dose combination 800/150 mg once daily in ART-naïve patients TMC114FD2HTX3001 is a randomized, active-controlled, double blind, Phase III trial to evalate the efficacy and safety of darunavir/cobicistat/emtricitabine/tenofovir alafenamide versus darunavir/cobicistat fixed-dose combination + emtricitabine/tenofovir disoproxil fumarate.
Icelandic: stigs samanburðarrannsókn með virku lyfi til að meta verkun og öryggi darunavirs/cobicistats/emtricitabins/tenofovir alafenamids samanborið við darunavir/cobicistat í fastri skammtasamsetningu + emtricitabin/tenofovir disoproxil fumarat.
English: Based on theoretical considerations REZOLSTA is expected to increase these sedative/hypnotic plasma concentrations.
Icelandic: Byggt á fræðilegum athugunum er búist við að REZOLSTA auki plasmaþéttni þessara róandi lyfja/svefnlyfja.
English: Based on theoretical considerations REZOLSTA is expected to increase lumefantrine plasma concentrations.
Icelandic: Byggt á fræðilegum athugunum er búist við að REZOLSTA auki plasmaþéttni lumefantrins.
English: REZOLSTA 800 mg/150 mg film-coated tablets darunavir/cobicistat
Icelandic: REZOLSTA 800/150 mg filmuhúðaðar töflur darunavir/cobicistat
English: (CYP3A and/or P-glycoprotein inhibition)
Icelandic: (CYP3A og/eða P-glykóprótein hömlun)
English: Cobicistat No clinically relevant pharmacokinetic differences due to gender have been identified for cobicistat.
Icelandic: Cobicistat Klínískt marktækur munur á lyfjahvörfum cobicistats milli kynja hefur ekki komið í ljós.
English: Based on theoretical considerations rifampin is expected to decrease darunavir and/or cobicistat plasma concentrations.
Icelandic: Byggt á fræðilegum athugunum má búast við að rifampicin minnki plasmaþéttni darunavirs og/eða cobicistats.
English: darunavir/ ritonavir 800/100 mg once daily N = 343
Icelandic: darunavir/ ritonavir 800/100 mg einu sinni á sólarhring
English: The evidence of efficacy of darunavir/ritonavir 800/100 mg once daily is based on the analyses of 192 week data from the randomised, controlled, open-label Phase III trial ARTEMIS in antiretroviral treatment-naïve HIV-1 infected patients comparing darunavir/ritonavir 800/100 mg once daily with lopinavir/ritonavir 800/200 mg per day (given as a twice-daily or as a once-daily regimen).
Icelandic: stigs samanburðarrannsókninni ARTEMIS hjá HIV-1 sýktum sjúklingum sem ekki hafa áður fengið andretróveirumeðferð, þar sem darunavir/ritonavir 800/100 mg einu sinni á sólarhring var borið saman við lopinavir/ritonavir 800/200 mg á sólarhring (gefið annaðhvort tvisvar eða einu sinni á sólarhring).
English: Colchicine (if you have kidney/liver problems) to treat gout or familial Mediterranean fever The combination product lopinavir/ritonavir anti-HIV medicine
Icelandic: Colchicin (ef um er að ræða nýrna/lifrarvandamál)
English: Second trimester of pregnancy N=7
Icelandic: + OBR N = 313
English: Based on theoretical considerations REZOLSTA is expected to increase metformin plasma concentrations.
Icelandic: Byggt á fræðilegum athugunum er búist við að REZOLSTA auki plasmaþéttni metformins.
English: HIV-1 RNA < 50 copies/mL Virologic failure No virologic data in 48-week window
Icelandic: HIV-1 RNA < 1 log10 lækkun frá upphafsgildi og ≥ 50 eintök/ml í viku
English: (inhibition of CYP3A)
Icelandic: (CYP3A virkjun)
English: For these neuroleptics, consider reducing the dose of the neuroleptic upon co-administration with REZOLSTA.
Icelandic: Íhuga ber að minnka skammta þessara geðrofslyfja ef þau eru gefin samhliða REZOLSTA.
English: (CYP3A and/or P-glycoprotein inhibition).
Icelandic: (CYP3A og/eða P-glykóprótein hömlun).
English: CD4+ cell count mean change from baseline
Icelandic: Meðalbreyting CD4+ frumutalningar frá upphafsgildi
English: Based on theoretical considerations REZOLSTA is expected to increase rilpivirine plasma concentrations.
Icelandic: Byggt á fræðilegum athugunum er búist við að REZOLSTA auki plasmaþéttni rilpivirins.
English: REZOLSTA and dolutegravir can be used without dose adjustments.
Icelandic: Nota má REZOLSTA og sýrubindandi lyf samhliða án þess að breyta skömmtum.
English: Based on theoretical considerations these anticonvulsants are expected to decrease darunavir and/or cobicistat plasma concentrations.
Icelandic: Byggt á fræðilegum athugunum er búist við að þessi flogaveikilyf minnki plasmaþéttni darunavirs og/eða cobicistats.
English: Among 1,968 treatment-experienced patients receiving darunavir co-administered with ritonavir 600/100 mg twice daily, 236 patients were co-infected with hepatitis B or C. Co-infected patients were more likely to have baseline and treatment emergent hepatic transaminase elevations than those without chronic viral hepatitis (see section 4.4).
Icelandic: 1.968 sjúklinga sem áður höfðu fengið meðferð, sem fengu darunavir, ásamt ritonaviri 600/100 mg tvisvar sinnum á sólarhring, voru 236 sjúklingar sem einnig voru sýktir af lifrarbólgu
English: Musculoskeletal abnormalities
Icelandic: Algengar vöðvaþrautir
English: Imputations according to the Snapshot algorithm.
Icelandic: Snapshot algrím
English: Interaction not studied with any of the components of REZOLSTA.
Icelandic: Engar rannsóknir á milliverkunum hafa verið gerðar við innihaldsefni REZOLSTA.
English: Based on theoretical considerations REZOLSTA is expected to increase these calcium channel blocker plasma concentrations.
Icelandic: Byggt á fræðilegum athugunum er búist við að REZOLSTA auki plasmaþéttni þessara kalsíumgangaloka.
English: Triazolam or oral (taken by mouth) midazolam to help you sleep and/or relieve anxiety Sildenafil to treat a heart and lung disorder called pulmonary arterial hypertension.
Icelandic: Sildenafil til að meðhöndla hjarta- og lungnasjúkdóm sem kallast lungnaslagæðaháþrýstingur.
English: The resistance profile of REZOLSTA is driven by darunavir.
Icelandic: Upplýsingar um ónæmi REZOLSTA tengjast darunaviri.
English: REZOLSTA should be used with caution in patients with mild or moderate hepatic impairment (see sections 4.2, 4.3 and 5.2).
Icelandic: Vegna aukins styrks óbundins darunavirs í plasma skal nota REZOLSTA með varúð handa sjúklingum með vægt eða í meðallagi skerta lifrarstarfsemi (sjá kafla 4.2, 4.3 og 5.2).
English: The effects of other medicines might be influenced if you take REZOLSTA.
Icelandic: Notkun REZOLSTA getur haft áhrif á verkun eftirtalinna lyfja.
English: Based on theoretical considerations REZOLSTA may increase methadone plasma concentrations.
Icelandic: Byggt á fræðilegum athugunum er búist við að REZOLSTA auki plasmaþéttni metadons.
English: Based on theoretical considerations St John's wort is expected to decrease darunavir and/or cobicistat plasma concentrations.
Icelandic: Byggt á fræðilegum athugunum er búist við að jóhannesarjurt minnki plasmaþéttni darunavirs og/eða cobicistats.
English: Myalgia
Icelandic: Milliverkun
English: REZOLSTA can be co-administered with proton pump inhibitors without dose adjustments.
Icelandic: Nota má REZOLSTA samhliða prótónupumpuhemlum án þess að breyta þurfi skömmtum.
English: Imputations according to the TLOVR algorithm Last Observation Carried Forward imputation
Icelandic: 8, staðfest í næstu skoðun; veirumagn jókst á ný:
English: Metabolism and nutrition disorders Common anorexia, hypercholesterolaemia, hypertriglyceridaemia
Icelandic: - Clorazepat, diazepam, estazolam, flurazepam (lyf við svefnleysi og kvíða).
English: Do not take REZOLSTA - if you are allergic to darunavir, cobicistat or any of the other ingredients of this medicine (listed in section 6).
Icelandic: - ef um er að ræða ofnæmi fyrir darunaviri, cobicistati eða einhverju öðru innihaldsefni lyfsins
English: Treatment-naïve darunavir/cobicistat 800/150 mg once daily N = 295
Icelandic: Allir þátttakendur darunavir/cobicistat 800/150 mg einu sinni á sólarhring
English: PROTON PUMP INHIBITORS Dexlansoprazole
Icelandic: PRÓTÓNUPUMPUHEMLAR Dexlansoprazol
English: Efficacy of darunavir 800 mg once daily co-administered with 150 mg cobicistat once daily in ART-naïve and ART-experienced patients
Icelandic: Verkun darunavirs 800 mg einu sinni á sólarhring, ásamt 150 mg af cobicistati einu sinni á sólarhring hjá sjúklingum sem ekki hafa áður fengið meðferð með andretróveirulyfjum og sjúklingum sem hafa áður fengið meðferð með andretróveirulyfjum
English: HIV-1 RNA < 50 copies/mL mean HIV-1 RNA log change from baseline (log10 copies/mL) CD4+ cell count mean change from baseline
Icelandic: RNA log breytingar frá upphafsgildi (log10 eintök/ml)
English: Based on theoretical considerations REZOLSTA is expected to increase these antiarrhythmic plasma concentrations.
Icelandic: Byggt á fræðilegum athugunum er búist við að REZOLSTA auki plasmaþéttni þessara ónæmisbælandi lyfja.
English: Osteonecrosis
Icelandic: Títantvíoxíð
English: TREATMENT FOR PREMATURE EJACULATION Dapoxetine
Icelandic: ÆXLISHEMJANDI LYF Dasatinib
English: Treatment-experienced darunavir/ritonavir 800/100 mg once daily N = 294
Icelandic: Niðurstöður darunavir/ ritonavir 800/100 mg einu sinni á sólarhring
English: 1 vial
Icelandic: 1 hettuglasi
English: Always check both dates!
Icelandic: Athugið báðar dagsetningarnar!
English: Wash your hands before continuing.
Icelandic: Þvoið hendurnar áður en haldið er áfram.